SANUWAVE (OTCMKTS: SNWV) CEO Kevin Richardson II is back on the road following last week's presentation at the LD Micro 500 virtual conference. On
The presentation is expected to detail how the addition of Celularity's UltraMIST® is a transformative event for SANUWAVE. The remaining three investor presentations planned for September will likely follow a similar theme- the acquisition created a transformative and game-changing moment for SANUWAVE.
Following the conclusion of the LD Micro event, shares of SANUWAVE traded higher by more than 5% as investors digested the news that more than
At the LD conference, SANUWAVE discussed the value drivers behind the UltraMIST® acquisition. Besides the immediately accretive acquisition of UltraMIST®, the company also secured premium licensing terms for two important biologics, Biovance and Interfyl, creating a comprehensive wound-care treatment platform that can effectively treat patients from discovery to closure. Additionally, an enhanced and trained sales force of roughly 100 people can immediately maximize and cross-sell the combined strength and complementary nature of UltraMIST® and dermaPACE®, SANUWAVE's flagship device.
SANUWAVE expects to seize the cross-selling opportunities from roughly 1000 customer accounts with only 15 that overlap to create a ramp in revenues in the current quarter. Moreover, revenue growth is expected to accelerate in the coming quarters and benefit from cost savings and economies of scale. In the Q&A following the presentation,
Following tomorrow's event, SANUWAVE will be at the HC Wainwright 22nd Annual
Busy Presentation Schedule In September
SANUWAVE is scheduled to present at four major virtual investor conferences this month. The message is expected to help investors understand the true value behinds this game-changing acquisition for SANUWAVE. It may also tighten the valuation disconnect between current stock price levels that neglect the enormous boost to revenues and EBITDA earnings.
The
Completed - The LD Micro 500 - Listen to the presentation HERE
Dates:
Company presentation:
Format: Corporate presentation and One-on-One Investor Meetings
The Global Chinese Financial Forum-Investing in Innovation
Dates:
Company presentation:
Format: Corporate presentation and One-on-One Investor Meetings
HC Wainwright 22nd Annual
Dates:
Company Presentation:
Format: Corporate presentation and One-on-One Investor Meetings
Dates:
Format: One-on-One Investor Meetings
Each presentation will be webcast live and is accessible through the Events section of
SANUWAVE's message is one of transformation for the company. The virtual conferences provide a forum for SANUWAVE to highlight the substantial growth opportunities inherent to its acquisition of Celularity's UltraMIST® assets. Further, SANUWAVE can show competitive differences and advantages compared to industry giants like
The message delivered at LD Micro was powerful. Simply stated, management explained that the transformative acquisition provides SANUWAVE with a platform of scale, immediately brings substantial recurring revenue, and gives SANUWAVE an end-to-end advanced wound care product portfolio. The entirety of that platform addresses the entire care pathway and is compelling to patients, providers, and payers.
Few, if any, other companies in the sector currently offer such a comprehensive treatment solution.
Disclaimers:
Media Contact
Company
Contact Person:
Email: editorial@soulstringmedia.com
Country:
Website: https://www.soulstringmedia.com
Source: www.abnewswire.com
.
(C) 2020 M2 COMMUNICATIONS, source